Frequent epigenetic inactivation of the SLIT2 gene in gliomas

Oncogene

Volumn 22, Issue 29, 2003, Pages 4611-4616

  Dallol, Ashraf ^a   Krex, Dietmar ^b   Hesson, Luke ^a   Eng, Charis ^c   Maher, Eamonn R ^a   Latif, Farida ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Glioma; Methylation; SLIT2

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; LIGAND;

ALLELE; ARTICLE; BRAIN TISSUE; BREAST TUMOR; CANCER CELL CULTURE; CANCER GENETICS; CARCINOGENESIS; COLONY FORMATION; COLORECTAL TUMOR; CONTROLLED STUDY; CPG ISLAND; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC ANALYSIS; GLIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG TUMOR; MICROSATELLITE MARKER; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROBO GENE; SAMPLING; SLIT2 GENE; TUMOR SUPPRESSOR GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BASE SEQUENCE; CENTRAL NERVOUS SYSTEM NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EXTRACHROMOSOMAL INHERITANCE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GLIOMA; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED;

EID: 0043170818     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206687     Document Type: Article

References (28)

1. Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER and Latif F. (2001). Oncogene, 20, 1509-1518.
2. Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HPH, Voutilainen R, Dahia P, Eng C, Maher ER and Latif F. (2001). Oncogene, 20, 7573-7577.
3. Brose K, Bland KS, Wang KH, Arnott D, Henzel W, Goodman CS, Tessier-Lavigne M and Kidd T. (1999). Cell, 96, 795-806.
4. Burbee DG, Forgacs E, Zöchbauer-Müller S, Shivakumar L, Gao B, Randle D, Virmani A, Bader S, Sekido Y, Latif F, Fong K, Gazdar AF, Lerman MI, White M and Minna JD. (2001). J. Natl. Cancer Inst., 93, 691-699.
5. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB and Aldape KD. (2002). Cancer Res., 62, 6205-6210.
6. Costello JF and Plass C. (2001). J. Med. Genet., 38, 285-303.
7. Dallol A, Da Silva NF, Viacava P, Minna JD, Maher ER and Latif F. (2002a). Cancer Res., 62, 5874-5880.
8. Dallol A, Forgacs E, Martinez A, Sekido Y, Walker R, Kishida T, Rabbitts P, Maher ER and Latif F. (2002b). Oncegene, 21, 3020-3028.
9. Dallol A, Morton D, Maher ER and Latif F. (2003). Cancer Res., 63, 1054-1058.
10. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP. (2000). Nat. Genet., 25, 315-319.
11. Dammann R, Yang G and Pfeifer GP. (2001). Cancer Res., 61, 3105-3109.
12. Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li JF, Kashuba V, Klein G and Zabarovsky ER. (2001). Proc. Natl. Acad. Sci. USA, 98, 7504-7509.
13. Greger V, Debus N, Lohmann D, Hopping W, Passarge E and Horsthemke B. (1994). Hum. Genet., 94, 491-496.
14. Herman JG, Graft JR, Myohanen S, Nelkin BD and Baylin SB. (1996). Proc. Natl. Acad. Sci. USA, 93, 9821-9826.
15. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR and Linehan WM. (1994). Proc. Natl. Acad. Sci. USA, 91, 9700-9704.
16. Holland EC. (2001). Nat. Rev. Genet., 2, 120-129.
17. Jones PA. (1999). Trends Genet., 15, 34-37.
18. Jones PA and Baylin SB. (2002). Nat. Rev. Genet., 3, 415-428.
19. Lo KW, Kwong J, Hui ABY, Chan SYY, To KF, Chan SC, Chow LSN, Teo PML, Johnson PJ and Huang DP. (2001). Cancer Res., 61, 3877-3881.
20. Louis DN, Pomeroy SL and Cairncross JG. (2002). Cancer Cell, 1, 125-128.
21. Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW and Clifford SC. (2002). Cancer Res., 62, 5906-5911.
22. Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F and Maher ER. (2001). Cancer Res., 61, 7277-7281.
23. Rajagopalan S, Vivancos V, Nicolas E and Dickson BJ. (2000). Cell, 103, 1033-1045.
24. Simpson JH, Bland KS, Fetter RD and Goodman CS. (2000). Cell, 103, 1019-1032.
25. Stein E and Tessier-Lavigne M. (2001). Science, 291, 1928-1938.
26. Wong K, Ren XR, Huang YZ, Xie Y, Liu G, Saito H, Tang H, Wen L, Brady-Kalnay SM, Mei L, Wu JY, Xiong WC and Rao Y. (2001). Cell, 107, 209-221.
27. Xian J, Clark KJ, Fordham R, Pannell R, Rabbitts TH and Rabbitts PH. (2001). Proc. Natl. Acad. Sci. USA, 98, 15062-15066.
28. Yin D, Dong X, Hofmann WK, Miller CW, Black KL and Koeffler HP. (2002). Oncogene, 21, 8372-8378.